ClinicalTrials.gov
public full text
Public Domain
Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS
This research project entails delivery of a personalized antisense oligonucleotide (ASO) drug designed for individual participants with amyotrophic lateral sclerosis (ALS) due to a pathogenic variant in CHCHD10
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS#1140480
- Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS#877951
- SafeSense: An open-access safety atlas for antisense oligonucleotides adverse events in human.#480942
- The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis#390886
- Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS#847179
Record · ID 893260
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive